Disparate SARS-CoV-2 infection outcomes abound, but what makes SARS-CoV-2 bound for rebound?

The global research community attacked the COVID-19 pandemic and its causative agent, SARS-CoV-2, with intense ferocity. Over the past 4 years, one could argue that SARS-CoV-2 was the most intensely studied virus on the planet, dwarfing publication outputs of important pathogens such as HIV and influenza virus: by using PubMed as a proxy for research output, on 30 July 2024 searching for “SARS-CoV-2” yielded 232 127 results spanning 2020 to 2024 while “HIV” and “influenza” yielded 73 112 and 31 877 for the same period, respectively.